DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Etaracizumab
Etaracizumab
The Extracellular Matrix: an Accomplice in Gastric Cancer Development and Progression
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Tanibirumab (CUI C3490677) Add to Cart
The Two Tontti Tudiul Lui Hi Ha Unit
Arming Tumor-Associated Macrophages to Reverse Epithelial
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
| Hao Watatu with Other Mamma
(INN) for Biological and Biotechnological Substances
Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression
Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
Humanization of Antibodies Using a Machine Learning Approach on Large-Scale Repertoire Data
Drug-Based Optical Agents: Infiltrating Clinics at Lower Risk
(INN) for Biological and Biotechnological Substances
Electrolyte Disorders Associated with the Use of Anticancer Drugs
Top View
6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Wo 2010/095940 A2
(12) Patent Application Publication (10) Pub. No.: US 2017/0152480 A1 Jensen (43) Pub
Integrins As Therapeutic Targets: Successes and Cancers
Use of Antiangiogenic Therapies in Pediatric Solid Tumors
Antibody Therapy of Cancer
Selecting Potential Targetable Biomarkers For
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
Search for Therapeutic Targets at the Contact Points of the Tumor Cell with Its Extracellular Matrix in Neuroblastic Tumors
(2006.01) C07d 413/14
Pharmacological and Clinical Importance of Integrin Antagonists
( 12 ) Patent Application Publication
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Anti-Alphavbeta3 Monoclonal Antibody EMD 525797 (CUI C2830088) Add to Cart
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
Anti-Angiogenic Alternatives to VEGF Blockade Khan, Kabir A; Bicknell, Roy
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Anti-Angiogenic Alternatives to VEGF Blockade
(INN) for Biological and Biotechnological Substances
Tumor-Selective Response to Antibody-Mediated Targeting Of
Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma
(12) United States Patent (10) Patent No.: US 8,802.374 B2 Jensen (45) Date of Patent: Aug
Review Research
Assessment of the Evolution of Cancer Treatment Therapies
Β1 and Β3 Integrins in Breast, Prostate and Pancreatic Cancer: a Novel Implication (Review)
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
WO 2017/189679 Al 02 November 2017 (02.11.2017) W !P O PCT